The Management Board’s oversight role covers the full range of EMA programmes and activities, making sure that the Agency works effectively and co-operates successfully with partner organisations across the EU and beyond. In 2023, our attention was focused on ongoing initiatives to address medicines shortages and the implementation of the Clinical Trials Information System (CTIS).
The CTIS was made mandatory on 31 January and, over the course of the year, the Board was pleased to see the number of clinical trial submissions grow from 100 new initial clinical trials in February 2023 to over 190 in October 2023. This is a testament to the hard work done to improve the performance of the system and enhance user experience…
